← Browse by Condition
Medical Condition
locally recurrent head and neck squamous cell carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06211335 Phase 1
Recruiting
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Enrollment
24 pts
Location
United States
Sponsor
University of California, Davi...
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI...